hypoxanthine has been researched along with Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharjee, A; Ament, Z; Hinson, HE; Irvine, HJ; Kimberly, WT; Molyneaux, BJ; Sheth, KN; Simard, JM; Wolcott, Z | 1 |
1 other study(ies) available for hypoxanthine and Stroke
| Article | Year |
|---|---|
Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide.
Topics: Administration, Intravenous; Biomarkers; Brain Edema; Glyburide; Humans; Hypoxanthine; Matrix Metalloproteinase 9; Stroke | 2022 |